Submission Details
| 510(k) Number | K252814 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 04, 2025 |
| Decision Date | February 19, 2026 |
| Days to Decision | 168 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K252814 is an FDA 510(k) clearance for the Profoject? Low Dead Space Syringe /Profoject? Tuberculin Syringe; Profoject? Low Dead Space Syringe with Needle /Profoject? Tuberculin Syringe with Needle; Profoject? Low Dead Space Syringe with Permanent Needle /Profoject? Tuberculin Syringe with Permanent Needle; Profoject? Low Dead Space Safety Syringe /Profoject? Tuberculin Safety Syringe, a Low Dead Space Piston Syringe (Class II — Special Controls, product code QNQ), submitted by CMT Health PTE., Ltd. (Singapore, SG). The FDA issued a Cleared decision on February 19, 2026, 168 days after receiving the submission on September 4, 2025. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5860.
| 510(k) Number | K252814 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 04, 2025 |
| Decision Date | February 19, 2026 |
| Days to Decision | 168 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | QNQ — Low Dead Space Piston Syringe |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5860 |
| Definition | A Low Dead Space Syringe Is A Piston Syringe Designed To Reduce Medication Waste. The Device Consists Of A Calibrated Hollow Barrel, A Moveable Plunger, And May Include A Needle. The Device Can Be Used By Health Care Professions Or For Self-injection By The Patient. |